ArticleCureus2026
Medication Abortion Failure in a Patient With Class III Obesity and Twin Gestation: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is a paucity of clinical data stratifying medication abortion (MAB) success rates by obesity class or multifetal gestation. With rising rates of class III obesity, it is important to assess the efficacy of current MAB protocols in this population. A 30-year-old G3P1011 at six weeks two days (6w2d) with a diamniotic, dichorionic twin gestation and a body mass index (BMI) of 53, elected for MAB. She received 200 mg oral mifepristone followed by two doses of 800 mcg buccal misoprostol over 48 hours. Minimal symptoms occurred initially, and she ultimately required manual vacuum aspiration 31 days later for retained products. This case highlights possible limitations of standard MAB regimens in class III obesity with twin gestation, suggesting altered pharmacokinetics and the need for further research to optimize care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.